Obstetrics, gynecology and reproductive medicine guidelines

Breast diseases

PubMed Free Full Text

Breast cancer treatment

Canada

• Cancer Care Ontario
  • The Prophylactic Use of Filgrastim in Patients with Breast Cancer [2009]
  • Management of ductal carcinoma in situ of the breast: a clinical practice guideline [2006]

• National Guideline Clearinghouse
  • The prophylactic use of filgrastim in patients with breast cancer. Program in Evidence-based Care [2009]

• Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer
  • Clinical practice guidelines for the care and treatment of breast cancer: 9. Follow-up after treatment for breast cancer (2005 update) [2005]
  • Clinical practice guidelines for the care and treatment of breast cancer: 15. Treatment for women with stage III or locally advanced breast cancer [2004]
  • Clinical practice guidelines for the care and treatment of breast cancer: breast radiotherapy after breast-conserving surgery (summary of the 2003 update) [2003]
  • Clinical practice guidelines for the care and treatment of breast cancer: the management of chronic pain in patients with breast cancer (summary of the 2001 update) [2001]
  • Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-positive breast cancer (summary of the 2001 update) [2001]
  • Clinical practice guidelines for the care and treatment of breast cancer: adjuvant systemic therapy for node-negative breast cancer (summary of the 2001 update) [2001]
  • Clinical practice guidelines for the care and treatment of breast cancer: 8. Adjuvant systemic therapy for women with node-positive breast cancer (2001 update) [2001]
  • Clinical practice guidelines for the care and treatment of breast cancer: 7. Adjuvant systemic therapy for women with node-negative breast cancer (2001 update) [2001]
  • Clinical practice guidelines for the care and treatment of breast cancer: 5. Management of ductal carcinoma in situ (DCIS) (2001 update) [2001]
  • Clinical practice guidelines for the care and treatment of breast cancer: 11. Lymphedema [2001]
  • Clinical practice guidelines for the care and treatment of breast cancer: 10. The management of chronic pain in patients with breast cancer (2001 update) [2001]
  • Clinical practice guidelines for the care and treatment of breast cancer: 1. The palpable breast lump: information and recommendations to assist decision-making when a breast lump is detected [1998]
  • Clinical practice guidelines for the care and treatment of breast cancer

Europe

• Annals of Oncology
  • Third consensus on medical treatment of metastatic breast cancer [2009]

• Central European Cooperative Oncology Group
  • Third consensus on medical treatment of metastatic breast cancer [2009]

• European Society of Mastology
  • Role of complementary and alternative medicine in the management of early breast cancer [2006]
  • Guidelines on endocrine therapy of breast cancer [2002]

International

• Annals of Oncology
  • Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009 [2009]
  • Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005 [2005]

• Breast Health Global Initiative
  • Locally advanced breast cancer : Treatment guideline implementation with particular attention to low- and middle-income countries [2008]
  • Guideline implementation for breast healthcare in low- and middle-Income countries: Treatment resource allocation [2008]
  • Effective but cost-prohibitive drugs in breast cancer treatment : A clinician's perspective [2008]

• Cochrane Library
  • Systemic therapy for treating locoregional recurrence in women with breast cancer
  • Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus)
  • Specialist breast care nurses for supportive care of women with breast cancer
  • Single agent versus combination chemotherapy for metastatic breast cancer
  • Sequencing of chemotherapy and radiation therapy for early breast cancer
  • Psychological interventions for women with metastatic breast cancer
  • Platinum containing regimens for metastatic breast cancer
  • Physical therapies for reducing and controlling lymphoedema of the limbs
  • LHRH agonists for adjuvant therapy of early breast cancer in premenopausal women
  • High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with metastatic breast cancer
  • High dose chemotherapy and autologous bone marrow or stem cell transplantation versus conventional chemotherapy for women with early poor prognosis breast cancer
  • Follow-up strategies for women treated for early breast cancer
  • Exercise for women receiving adjuvant therapy for breast cancer
  • Chemotherapy alone versus endocrine therapy alone for metastatic breast cancer
  • Benzo-pyrones for reducing and controlling lymphoedema of the limbs
  • Antitumour antibiotic containing regimens for metastatic breast cancer
  • Addition of drug/s to a chemotherapy regimen for metastatic breast cancer

• Endocrine-Related Cancer
  • Consensus statement. Workshop on therapeutic resistance in breast cancer: impact of growth factor signalling pathways and implications for future treatment [2005]

• Journal of the National Cancer Institute
  • International Guidelines for Management of Metastatic Breast Cancer: Can Metastatic Breast Cancer Be Cured? [2010]
  • International Guidelines for Management of Metastatic Breast Cancer: Combination vs Sequential Single-Agent Chemotherapy [2009]

• National Guideline Clearinghouse
  • Guideline implementation for breast healthcare in low- and middle-income countries: treatment resource allocation. Breast Health Global Initiative [2008]

Japan

• Japanese Journal of Clinical Oncology
  • The Transition of Breast Cancer Treatment and Japan Clinical Oncology Group Research Over Two Decades [2012]

New Zealand

• National Guideline Clearinghouse
  • Systemic therapy: endocrine therapies. In: Management of early breast cancer. New Zealand Guidelines Group [2009]
  • Systemic therapy: chemotherapy regimens. In: Management of early breast cancer. New Zealand Guidelines Group [2009]
  • Follow-up. In: Management of early breast cancer. New Zealand Guidelines Group [2009]

Spain

• Health and Quality of Life Outcomes
  • Health-related quality of life in Spanish breast cancer patients: a systematic review [2011]

United Kingdom

• Health Technology Assessment
  • Time to full publication of studies of anti-cancer medicines for breast cancer and the potential for publication bias: a short systematic review [2008]
  • Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy [2006]

• National Guideline Clearinghouse
  • Eribulin for the treatment of locally advanced or metastatic breast cancer. National Institute for Health and Clinical Excellence (NICE) [2012]

• National Institute for Health and Clinical Excellence
  • Breast cancer (metastatic hormone-receptor) - lapatinib and trastuzumab (with aromatase inhibitor) [2012]
  • Breast cancer (advanced) - eribulin [2012]

United States of America

• American College of Radiology
  • Locally Advanced Breast Cancer [2011]

• American Society of Clinical Oncology
  • Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update [2012]
  • American Society of Clinical Oncology Executive Summary of the Clinical Practice Guideline Update on the Role of Bone-Modifying Agents in Metastatic Breast Cancer [2011]
  • American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer [2010]
  • American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction [2009]
  • American Society of Clinical Oncology 2006 Update of the Breast Cancer Follow-Up and Management Guidelines in the Adjuvant Setting [2006]

• National Cancer Institute
  • Breast Cancer: Treatment

• National Guideline Clearinghouse
  • Breast cancer follow-up and management after primary treatment: American Society of Clinical Oncology clinical practice guideline update [2013]
  • American Society of Clinical Oncology clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer [2011]
  • ACR Appropriateness Criteria® locally advanced breast cancer [2011]
  • American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor–positive breast cancer [2010]
  • American Society of Clinical Oncology clinical practice guideline update on the use of pharmacologic interventions including tamoxifen, raloxifene, and aromatase inhibition for breast cancer risk reduction [2009]

Articles in journals

• Annals Academy of Medicine Singapore
  • The feminist approach in the decision-making process for treatment of women with breast cancer [2006]

• Annals of Oncology
  • CMF revisited in the 21st century [2012]
  • Targeting the Phosphoinositide-3 (PI3) Kinase Pathway in Breast Cancer [2011]
  • Long-term toxic effects of adjuvant chemotherapy in breast cancer [2011]
  • What is the role of chemotherapy in estrogen receptor-positive, advanced breast cancer? [2009]
  • Role of combination therapy with aromatase and cyclooxygenase-2 inhibitors in patients with metastatic breast cancer [2009]
  • Role of biologic therapy and chemotherapy in hormone receptor- and HER2-positive breast cancer [2009]
  • Effective oral chemotherapy for breast cancer: pillars of strength [2008]
  • Anthracycline–trastuzumab regimens for HER2/neu-overexpressing breast cancer: current experience and future strategies [2008]
  • A review of the use of trastuzumab (Herceptin(R)) plus vinorelbine in metastatic breast cancer [2008]
  • Adjuvant treatment of breast cancer: sequence and duration of hormonal therapy [2006]
  • New developments in the treatment of metastatic breast cancer: from chemotherapy to biological therapy [2005]
  • Neo-adjuvant therapy in breast cancer [2005]
  • An integrated approach for tailored treatment in breast cancer [2005]
  • Adjuvant treatment for early breast cancer [2005]

• Annals of Surgical Oncology
  • Metastasectomy and Surgical Resection of the Primary Tumor in Patients With Stage IV Breast Cancer [2010]

• Asian Pacific Journal of Cancer Prevention
  • Genomics and pharmacogenomics of breast cancer: current knowledge and trends [2011]

• Australian Family Physician
  • Survivorship care after breast cancer [2008]
  • Life after breast cancer [2006]
  • Breast Cancer. Guiding your patient through treatment [2006]
  • Management of early breast cancer - The current approach [2005]

• Biology of Reproduction
  • Targeting Breast and Prostate Cancers Through Their Hormone Receptors [2005]

• BMC Cancer
  • Return to work of breast cancer survivors: a systematic review of intervention studies [2009]

• BMC Medical Research Methodology
  • Reasons for and against participation in studies of medicinal therapies for women with breast cancer: a debate [2012]

• Breast Cancer
  • Recent perspectives of endocrine therapy for breast cancer [2007]
  • Optimizing the antihormonal treatment and prevention of breast cancer [2007]
  • Economic evaluation of the prevention and treatment of breast cancer--present status and open issues [2007]
  • Current status of health outcome assessment of medical treatment in breast cancer [2007]
  • Current clinical trials of endocrine therapy for breast cancer [2007]

• Breast Cancer Research
  • Therapeutic targets for bone metastases in breast cancer [2011]
  • Notch signaling as a therapeutic target for breast cancer treatment? [2011]
  • Mutations in the PI3K pathway: role in tumor progression and therapeutic implications in breast cancer [2011]
  • Luminal B breast cancer and novel therapeutic targets [2011]
  • Estrogen receptor degradation: a CUE for endocrine resistance? [2011]
  • Cannibalism, cell survival, and endocrine resistance in breast cancer [2011]
  • Recent advances in systemic therapy. Advances in neoadjuvant (primary) systemic therapy with cytotoxic agents [2009]
  • Recent advances in systemic therapy. Advances in adjuvant systemic chemotherapy of early breast cancer [2009]
  • New Diagnostics and Biological Predictors of Outcome in Early Breast Cancer [2009]
  • Are we HER-ting for innovation in neoadjuvant breast cancer trial design? [2009]
  • Molecular targeted therapies for breast cancer treatment [2008]

• British Journal of Cancer
  • Beyond trastuzumab: novel therapeutic strategies in HER2-positive metastatic breast cancer [2012]
  • The treatment of early breast cancer in women over the age of 70 [2011]
  • A systematic review to establish the frequency of cyclooxygenase-2 expression in normal breast epithelium, ductal carcinoma in situ, microinvasive carcinoma of the breast and invasive breast cancer [2011]

• Canadian Family Physician
  • Management of secondary lymphedema related to breast cancer [2010]

• Canadian Medical Association Journal
  • Effects of exercise on breast cancer patients and survivors: a systematic review and meta-analysis [2006]

• Cancer
  • Conservative and dietary interventions for cancer-related lymphedema [2011]
  • BRCA Mutation Testing in Determining Breast Cancer Therapy [2011]
  • A woman's heart: the impact of adjuvant endocrine therapy on cardiovascular health [2009]

• Cancer Biology & Therapy
  • Resistance to HER2-directed antibodies and tyrosine kinase inhibitors [2011]

• Clinical Breast Cancer
  • Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit? [2009]
  • Enhancing the efficacy of hormonal agents with selected targeted agents [2009]
  • A question of duration: do patients with early-stage breast cancer need more than five years of adjuvant endocrine therapy? [2009]
  • A 2009 update on the treatment of patients with hormone receptor-positive breast cancer [2009]

• Clinical Cancer Research
  • New Strategies in HER2-Overexpressing Breast Cancer: Many Combinations of Targeted Drugs Available [2011]
  • Exploring Breast Cancer Estrogen Disposition: The Basis for Endocrine Manipulation [2011]
  • Eribulin Mesylate [2011]
  • Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac Problems [2008]
  • Skeletal Complications of Breast Cancer Therapies [2006]
  • A Meta-Analysis on the Interaction between HER-2 Expression and Response to Endocrine Treatment in Advanced Breast Cancer [2005]

• Clinical Journal of Oncology Nursing
  • Complementary and alternative medicine use among women with breast cancer: a systematic review [2010]

• Clinical Medicine & Research
  • NSABP Breast Cancer Clinical Trials: Recent Results and Future Directions [2003]

• Clinics
  • The effects of dietary supplementation with Agaricales mushrooms and other medicinal fungi on breast cancer: evidence-based medicine [2011]

• Critical Reviews in Oncogenesis
  • Intrinsic and Acquired Resistance to HER2-Targeted Therapies in HER2 Gene-Amplified Breast Cancer: Mechanisms and Clinical Implications [2012]

• Current Eye Research
  • Breast Cancer Medications and Vision: Effects of Treatments for Early-stage Disease [2011]

• Deutsches Ärzteblatt International
  • Adjuvant Therapy for Women Over Age 65 With Breast Cancer [2011]

• Discovery Medicine
  • Tracking the Seed and Tending the Soil: Evolving Concepts in Metastatic Breast Cancer [2012]

• Endocrine Reviews
  • Cracking the Estrogen Receptor's Posttranslational Code in Breast Tumors [2011]
  • Crosstalk between the Estrogen Receptor and the HER Tyrosine Kinase Receptor Family: Molecular Mechanism and Clinical Implications for Endocrine Therapy Resistance [2008]

• Endocrine-Related Cancer
  • Antiprogestins in breast cancer treatment: are we ready? [2012]
  • Killing the second messenger: targeting loss of cell cycle control in endocrine-resistant breast cancer [2011]
  • Target-based therapies in breast cancer: current status and future perspectives [2009]
  • Hormone receptor-positive early breast cancer: controversies in the use of adjuvant chemotherapy [2009]
  • Src as a therapeutic target in anti-hormone/anti-growth factor-resistant breast cancer [2006]
  • Resistance to endocrine therapy in breast cancer: exploiting estrogen receptor/growth factor signaling crosstalk [2006]
  • Is oestrogen receptor- {beta} a predictor of endocrine therapy responsiveness in human breast cancer? [2006]
  • The mechanisms and managements of hormone-therapy resistance in breast and prostate cancers [2005]
  • The NF{kappa}B pathway and endocrine-resistant breast cancer [2005]
  • Overview of the impact of conventional systemic therapies on breast cancer [2005]
  • Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer [2005]
  • Growth factor signalling in clinical breast cancer and its impact on response to conventional therapies: the Edinburgh experience [2005]
  • Breast cancer vaccines: maximizing cancer treatment by tapping into host immunity [2005]
  • Effects of estrogen deprivation due to breast cancer treatment [2004]

• Exercise and Sport Sciences Reviews
  • Balancing Lymphedema Risk: Exercise Versus Deconditioning for Breast Cancer Survivors [2010]

• Expert Opinion on Therapeutic Targets
  • Integrin a3ß1 as a breast cancer target [2011]

• Frontiers in Bioscience
  • Triterpenoids as potential agents for the chemoprevention and therapy of breast cancer [2011]

• Future Oncology
  • Emerging therapeutic targets in breast cancer bone metastasis [2010]

• Indian Journal of Medical Research
  • Endpoints in advanced breast cancer: methodological aspects & clinical implications [2011]

• Japanese Journal of Clinical Oncology
  • Targeted Therapy in Breast Cancer: Current Status and Future Directions [2010]
  • Current Trends and Controversies over Pre-operative Chemotherapy for Women with Operable Breast Cancer [2007]

• Journal of Biomedicine and Biotechnology
  • TP53 Status and Response to Treatment in Breast Cancers [2011]

• Journal of Cancer Research and Therapeutics
  • Psychostimulants for chemotherapy induced cognitive changes in cancer [2011]

• Journal of Cancer Survivorship
  • Quality of life among Latina breast cancer patients: a systematic review of the literature [2011]

• Journal of Clinical Investigation
  • Targeted therapies for breast cancer [2011]

• Journal of Clinical Oncology
  • Phosphatidylinositol 3-Kinase and Antiestrogen Resistance in Breast Cancer [2011]

• Journal of Experimental & Clinical Cancer Research
  • Health-related quality of life in breast cancer patients: a bibliographic review of the literature from 1974 to 2007 [2009]

• Journal of Nuclear Medicine
  • The Role of Radiotracer Imaging in the Diagnosis and Management of Patients with Breast Cancer: Part 2--Response to Therapy, Other Indications, and Future Directions [2009]
  • Response to Therapy in Breast Cancer [2009]

• Journal of the National Cancer Institute
  • Quality-of-Life Measurement in Randomized Clinical Trials in Breast Cancer: An Updated Systematic Review (2001–2009) [2011]
  • Dose-Dense Chemotherapy in Nonmetastatic Breast Cancer: A Systematic Review and Meta-analysis of Randomized Controlled Trials [2010]
  • Multiple-Treatments Meta-analysis of Chemotherapy and Targeted Therapies in Advanced Breast Cancer [2008]
  • Risk of Cardiac Death After Adjuvant Radiotherapy for Breast Cancer [2005]
  • Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-Analysis [2005]

• Maturitas
  • Progress in endocrine approaches to the treatment and prevention of breast cancer [2011]

• Medical Journal of Australia
  • Systemic adjuvant therapies for early breast cancer: 15-year results for recurrence and survival [2005]
  • Breast cancer in Western Australia: clinical practice and clinical guidelines [2004]

• Molecular Medicine
  • Transcription Factor Networks as Targets for Therapeutic Intervention of Cancer: The Breast Cancer Paradigm [2011]

• Nature Reviews Cancer
  • Dynamic modeling of estrogen signaling and cell fate in breast cancer cells [2011]

• Nature Reviews Clinical Oncology
  • Use of neoadjuvant data to design adjuvant endocrine therapy trials for breast cancer [2012]

• Nigerian Journal of Clinical Practice
  • Review of hormonal treatment of breast cancer [2012]

• Oncologist
  • Targeting the Phosphatidylinositol 3-Kinase Signaling Pathway in Breast Cancer [2011]
  • Symptom Management in Metastatic Breast Cancer [2011]
  • In the End What Matters Most? A Review of Clinical Endpoints in Advanced Breast Cancer [2011]
  • Early Breast Cancer in the Older Woman [2011]
  • Current Targeted Therapies in Breast Cancer: Clinical Applications in the Elderly Woman [2011]
  • Combining Emerging Agents in Advanced Breast Cancer [2011]
  • Cardiovascular Complications of Breast Cancer Therapy in Older Adults [2011]
  • A Review of an Unfavorable Subset of Breast Cancer: Estrogen Receptor Positive Progesterone Receptor Negative [2011]
  • The HER-2 Receptor and Breast Cancer: Ten Years of Targeted Anti-HER-2 Therapy and Personalized Medicine [2009]
  • Metastatic Breast Cancer: Therapeutic Options According to Molecular Subtypes and Prior Adjuvant Therapy [2009]

• Oncology
  • Mammalian target of rapamycin as a rational therapeutic target for breast cancer treatment [2013]

• Psycho-Oncology
  • A Contextual Approach to Understanding Breast Cancer Survivorship Among Latinas [2012]

• Radiation Oncology
  • Multidisciplinary approach of early breast cancer: The biology applied to radiation oncology [2010]

• Revista da Associação Médica Brasileira
  • Transcriptional profile and response to neoadjuvante chemotherapy in breast cancer [2011]

• Revista Latino-Americana de Enfermagem
  • Physiotherapy treatments for breast cancer-related lymphedema: a literature review [2009]

• Swiss Medical Weekly
  • Targeted therapies in breast cancer [2012]
  • Targeted therapy in breast cancer: what's new? [2011]

{Related topics}

• Clinical tools, medical calculators, unit conversions, statistics, clinical research tools
  • Treatment of breast cancer : Clinical tools, medical calculators

• Guidelines
  • Breast cancer treatment: vinca alkaloids
  • Breast cancer treatment: tyrosine kinase inhibitors
  • Breast cancer treatment: taxanes
  • Breast cancer treatment: surgery, radiotherapy
  • Breast cancer treatment: monoclonal antibodies
  • Breast cancer treatment: epothilones
  • Breast cancer treatment: bisphosphonates
  • Breast cancer treatment: aromatase inhibitors
  • Breast cancer treatment: antimetabolites
  • Breast cancer treatment: antiestrogens
  • Breast cancer treatment: anthracyclines
  • Breast cancer